- Home
- PRTG vs BFRG Comparison
PRTG vs BFRG Comparison
Compare PRTG & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTG
- BFRG
- Stock Information
- Founded
- PRTG 1973
- BFRG 2017
- Country
- PRTG British Virgin Islands
- BFRG United States
- Employees
- PRTG N/A
- BFRG N/A
- Industry
- PRTG Oil & Gas Production
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- PRTG Energy
- BFRG Technology
- Exchange
- PRTG Nasdaq
- BFRG Nasdaq
- Market Cap
- PRTG 17.7M
- BFRG 16.4M
- IPO Year
- PRTG N/A
- BFRG 2023
- Fundamental
- Price
- PRTG $8.85
- BFRG $1.27
- Analyst Decision
- PRTG
- BFRG
- Analyst Count
- PRTG 0
- BFRG 0
- Target Price
- PRTG N/A
- BFRG N/A
- AVG Volume (30 Days)
- PRTG 44.3K
- BFRG 172.6K
- Earning Date
- PRTG 08-26-2025
- BFRG 08-19-2025
- Dividend Yield
- PRTG N/A
- BFRG N/A
- EPS Growth
- PRTG N/A
- BFRG N/A
- EPS
- PRTG N/A
- BFRG N/A
- Revenue
- PRTG N/A
- BFRG N/A
- Revenue This Year
- PRTG N/A
- BFRG N/A
- Revenue Next Year
- PRTG N/A
- BFRG N/A
- P/E Ratio
- PRTG N/A
- BFRG N/A
- Revenue Growth
- PRTG N/A
- BFRG N/A
- 52 Week Low
- PRTG $2.10
- BFRG $1.23
- 52 Week High
- PRTG $23.01
- BFRG $4.84
- Technical
- Relative Strength Index (RSI)
- PRTG 65.34
- BFRG 32.35
- Support Level
- PRTG $8.08
- BFRG $1.25
- Resistance Level
- PRTG $10.25
- BFRG $1.39
- Average True Range (ATR)
- PRTG 0.87
- BFRG 0.07
- MACD
- PRTG 0.43
- BFRG -0.01
- Stochastic Oscillator
- PRTG 71.72
- BFRG 6.01
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.